Home > WHO scheduling recommendations on cannabis and cannabis-related substances. Commission on Narcotic Drugs - reconvened sixty-third session Vienna, 2–4 December 2020.

Commission on Narcotic Drugs. (2020) WHO scheduling recommendations on cannabis and cannabis-related substances. Commission on Narcotic Drugs - reconvened sixty-third session Vienna, 2–4 December 2020. Vienna: United Nations Economic and Social Council.

[img]
Preview
PDF (E/CN.7/2020/CRP.19 - Summary of the proceedings)
751kB
[img]
Preview
PDF (Implementation of the international drug control treaties 2020 - Draft report.)
240kB

External website: https://www.unodc.org/unodc/en/commissions/CND/Man...


1. At the 1st, 2nd and 4th meetings of its reconvened sixty-third session, on 2 and 4 December 2020, the Commission considered agenda item 5, entitled “Implementation of the international drug control treaties: changes in the scope of control of substances”.
2. For its consideration of item 5, the Commission had before it a conference room paper on the WHO scheduling recommendations on cannabis and cannabis-related substances, outlining the considerations of the recommendations by the Commission during its sixty-second and sixty-third sessions (E/CN.7/2020/CRP.19)....

WHO scheduling recommendations on cannabis and cannabis-related substances

The Commission took on 2 December 2020 action on these recommendations:

WHO recommendation to delete cannabis and cannabis resin from Schedule IV of the 1961 Convention: The Commission decided by 27 votes to 25 and with one abstention to follow this recommendation. Cannabis and cannabis resin will accordingly be deleted from Schedule IV of the 1961 Convention. They remain in Schedule I of the 1961 Convention and thus remain subject to all levels of control of the 1961 Convention.

WHO recommendation to move dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) and tetrahydrocannabinol (six isomers of delta-9-tetrahydrocannabinol), which are psychoactive components of cannabis, from the respective schedules of the 1971 Convention to Schedule I of the 1961 Convention, which already includes cannabis and cannabis resin: The Commission rejected by 23 votes to 28 with 2 abstentions the recommendation to add dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) to Schedule I of the 1961 Convention. Due to the conditionalities included in the WHO recommendations, the Commission therefore did not vote on the recommendation relating to the deletion of dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) from the 1971 Convention. It also did not vote on the recommendation to move tetrahydrocannabinol (six isomers of delta-9-tetrahydrocannabinol) from the 1971 Convention to the 1961 Convention.

WHO recommendation to delete extracts and tinctures of cannabis from Schedule I of the 1961 Convention: The Commission decided by 24 votes to 27 and with 2 abstentions not to adopt this recommendation.

WHO recommendation to add a footnote to Schedule I of the 1961 Convention to read “Preparations containing predominantly cannabidiol and not more than 0.2 per cent of delta-9-tetrahydrocannabinol are not under international control”: The Commission decided by 6 to 43 votes and with 4 abstentions not to add such a footnote.

Lastly, WHO recommendation to add certain preparations of dronabinol to Schedule III of the 1961 Convention: As the Commission had predetermined in a procedural decision, adopted at the beginning of the meeting, this recommendation was deemed rejected, due to the rejection of the recommendation to add dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) to Schedule I of the 1961 Convention.

Repository Staff Only: item control page